Point and Figure Charting Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Point and Figure Charting

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Judy who wrote (9230)	11/2/1998 5:33:00 PM
From: Nancy	Read Replies (1) of 34811

Next FDA play - PFE/MTC's Celebrex Subject: Celebrex Review Milestones Date: 11/1/98 8:56 PM Central Standard Time From: BigKNY3 Message-id: <19981101215626.18366.00002535@ng-fa1.aol.com> LSarmie: <<BigKNY, is there a time frame when celebra will be reviewed for approval?>> Here's an estimate of the Celebrex review milestones The FDA announced expedited review for Celebrex on August 24, 1998 (as per the handy Peabody Daily Log). An FDA Advisory Panel should be convened to review Celebrex in December, 1998 or January, 1999. According to their guidelines, the FDA must report the status of the Celebrex NDA by February 24, 1999. One final point: to date every NDA that has been given an FDA expedited review has been approved for marketing. Have PFun! BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next